help button home button Am J Pathol sign up for etoc
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poulsom, R.
Right arrow Articles by Stamp, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poulsom, R.
Right arrow Articles by Stamp, G. W.

American Journal of Pathology, Vol 141, 389-396, Copyright © 1992 by American Society for Investigative Pathology


REGULAR ARTICLES

Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia

R Poulsom, M Pignatelli, WG Stetler-Stevenson, LA Liotta, PA Wright, RE Jeffery, JM Longcroft, L Rogers and GW Stamp
ICRF/RCS Histopathology Unit, London, United Kingdom.

We undertook an in situ hybridization study to localize the mRNAs for the 72 kda type IV collagenase (MMP-2) and its specific inhibitor (TIMP- 2) in 12 colorectal carcinomas, 3 adenomas, and 4 uninvolved resection margins to see how their distributions correlated with that of the reported distribution of MMP-2 protein. Labeling for MMP-2 and TIMP-2 mRNAs was detectable in 10 of 12 carcinomas and in 2 of 3 adenomas. Unexpectedly, we found much stronger signals for MMP-2 and TIMP-2 mRNAs within the mesenchymal cells in the desmoplastic stroma, of endothelial and/or (myo)fibroblastic nature, rather than in tumor epithelial cells in which localization of MMP-2 was anticipated. Our data indicate that stromal cells may have the ability to synthesize a metalloproteinase that degrades basement membrane, and may together with the neoplastic epithelial cells participate actively in the tissue remodeling and disruption of the basement membrane integrity which is characteristic of invasive tumors.


This article has been cited by other articles:


Home page
IOVSHome page
G. A. Alyahya, M. Kolko, J. U. Prause, B. S. Nielsen, J. Wang, and S. Heegaard
Matrix Metalloproteinase-2 Is Expressed in Melanoma-Associated Spongiform Scleropathy
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 2806 - 2811.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
T Kirkegaard, A Hansen, E Bruun, and J Brynskov
Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease
Gut, May 1, 2004; 53(5): 701 - 709.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Gakiopoulou, L. Nakopoulou, A. Siatelis, I. Mavrommatis, E. G. Panayotopoulou, I. Tsirmpa, C. Stravodimos, and A. Giannopoulos
Tissue Inhibitor of Metalloproteinase-2 as a Multifunctional Molecule of Which the Expression Is Associated with Adverse Prognosis of Patients with Urothelial Bladder Carcinomas
Clin. Cancer Res., November 15, 2003; 9(15): 5573 - 5581.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
C. D Liapis and K. I Paraskevas
The pivotal role of matrix metalloproteinases in the development of human abdominal aortic aneurysms
Vascular Medicine, November 1, 2003; 8(4): 267 - 271.
[Abstract] [PDF]


Home page
Clin. Cancer Res.Home page
M. Daneshmand, D. A. E. Parolin, H. W. Hirte, P. Major, G. Goss, D. Stewart, G. Batist, W. H. Miller Jr., S. Matthews, L. Seymour, et al.
A Pharmacodynamic Study of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 in Metastatic Colorectal Cancer Patients
Clin. Cancer Res., July 1, 2003; 9(7): 2457 - 2464.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Masui, R. Doi, T. Koshiba, K. Fujimoto, S. Tsuji, S. Nakajima, M. Koizumi, E. Toyoda, S. Tulachan, D. Ito, et al.
RECK Expression in Pancreatic Cancer: Its Correlation with Lower Invasiveness and Better Prognosis
Clin. Cancer Res., May 1, 2003; 9(5): 1779 - 1784.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. R. Mertens, K. Steinmann, M. A. Alfonso-Jaume, A. En-Nia, Y. Sun, and D. H. Lovett
Combinatorial Interactions of p53, Activating Protein-2, and YB-1 with a Single Enhancer Element Regulate Gelatinase A Expression in Neoplastic Cells
J. Biol. Chem., July 5, 2002; 277(28): 24875 - 24882.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Orimo, Y. Tomioka, Y. Shimizu, M. Sato, S. Oigawa, K. Kamata, Y. Nogi, S. Inoue, M. Takahashi, T. Hata, et al.
Cancer-associated Myofibroblasts Possess Various Factors to Promote Endometrial Tumor Progression
Clin. Cancer Res., October 1, 2001; 7(10): 3097 - 3105.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Sun and M. E. Hemler
Regulation of MMP-1 and MMP-2 Production through CD147/Extracellular Matrix Metalloproteinase Inducer Interactions
Cancer Res., March 1, 2001; 61(5): 2276 - 2281.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
J. W. Slaton, K. Inoue, P. Perrotte, A. K. El-Naggar, D. A. Swanson, I. J. Fidler, and C. P. N. Dinney
Expression Levels of Genes that Regulate Metastasis and Angiogenesis Correlate with Advanced Pathological Stage of Renal Cell Carcinoma
Am. J. Pathol., February 1, 2001; 158(2): 735 - 743.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Brand, A. H. Baker, A. Perez-Cantó, A. Possling, M. Sacharjat, M. Geheeb, and W. Arnold
Treatment of Colorectal Liver Metastases by Adenoviral Transfer of Tissue Inhibitor of Metalloproteinases-2 into the Liver Tissue
Cancer Res., October 1, 2000; 60(20): 5723 - 5730.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
B. Passlick, W. Sienel, R. Seen-Hibler, W. Wöckel, O. Thetter, W. Mutschler, and K. Pantel
Overexpression of Matrix Metalloproteinase 2 Predicts Unfavorable Outcome in Early-Stage Non-Small Cell Lung Cancer
Clin. Cancer Res., October 1, 2000; 6(10): 3944 - 3948.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
M. Määttä, Y. Soini, A. Liakka, and H. Autio-Harmainen
Differential Expression of Matrix Metalloproteinase (MMP)-2, MMP-9, and Membrane Type 1-MMP in Hepatocellular and Pancreatic Adenocarcinoma: Implications for Tumor Progression and Clinical Prognosis
Clin. Cancer Res., July 1, 2000; 6(7): 2726 - 2734.
[Abstract] [Full Text]


Home page
JCOHome page
A. R. Nelson, B. Fingleton, M. L. Rothenberg, and L. M. Matrisian
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
J. Clin. Oncol., March 1, 2000; 18(5): 1135 - 1135.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
S. Caudroy, M. Polette, J.-M. Tournier, H. Burlet, B. Toole, S. Zucker, and P. Birembaut
Expression of the Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) and the Matrix Metalloproteinase-2 in Bronchopulmonary and Breast Lesions
J. Histochem. Cytochem., December 1, 1999; 47(12): 1575 - 1580.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. S. Kanwar, K. Ota, Q. Yang, J. Wada, N. Kashihara, Y. Tian, and E. I. Wallner
Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis
Am J Physiol Renal Physiol, December 1, 1999; 277(6): F934 - F947.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. F. Olumi, G. D. Grossfeld, S. W. Hayward, P. R. Carroll, T. D. Tlsty, and G. R. Cunha
Carcinoma-associated Fibroblasts Direct Tumor Progression of Initiated Human Prostatic Epithelium
Cancer Res., October 1, 1999; 59(19): 5002 - 5011.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
K.L. Pickett, G.J. Harber, A.A. DeCarlo, P. Louis, S. Shaneyfelt, L.J. Windsor, and M.K. Bodden
92K-GL (MMP-9) and 72K-GL (MMP-2) are Produced in vivo by Human Oral Squamous Cell Carcinomas and can Enhance FIB-CL (MMP-1) Activity in vitro
Journal of Dental Research, July 1, 1999; 78(7): 1354 - 1361.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
C. Munaut, T. Salonurmi, S. Kontusaari, P. Reponen, T. Morita, J.-M. Foidart, and K. Tryggvason
Murine Matrix Metalloproteinase 9 Gene. 5'-UPSTREAM REGION CONTAINS CIS-ACTING ELEMENTS FOR EXPRESSION IN OSTEOCLASTS AND MIGRATING KERATINOCYTES IN TRANSGENIC MICE
J. Biol. Chem., February 26, 1999; 274(9): 5588 - 5596.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. Polette, C. Gilles, V. Marchand, M. Lorenzato, B. Toole, J.-M. Tournier, S. Zucker, and P. Birembaut
Tumor Collagenase Stimulatory Factor (TCSF) Expression and Localization in Human Lung and Breast Cancers
J. Histochem. Cytochem., May 1, 1997; 45(5): 703 - 710.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Guo, S. Zucker, M. K. Gordon, B. P. Toole, and C. Biswas
Stimulation of Matrix Metalloproteinase Production by Recombinant Extracellular Matrix Metalloproteinase Inducer from Transfected Chinese Hamster Ovary Cells
J. Biol. Chem., January 3, 1997; 272(1): 24 - 27.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Y. Strongin, I. Collier, G. Bannikov, B. L. Marmer, G. A. Grant, and G. I. Goldberg
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
J. Biol. Chem., March 10, 1995; 270(10): 5331 - 5338.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
B. Himelstein, R Canete-Soler, E. Bernhard, and R. Muschel
Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells
J. Cell Sci., January 2, 1994; 107(2): 477 - 486.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Price, D. R. Greaves, and H. Watkins
Identification of Novel, Functional Genetic Variants in the Human Matrix Metalloproteinase-2 Gene. ROLE OF Sp1 IN ALLELE-SPECIFIC TRANSCRIPTIONAL REGULATION
J. Biol. Chem., March 2, 2001; 276(10): 7549 - 7558.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Society for Investigative Pathology.